"If you're a great company with great promise, there's money out there."

– Geoff Whitehead, principal with Flagship Ventures, on funding difficulties for stem cell firms

"The world of pharma is waking up [to the fact] that this is going to be the next frontier."

– Greg Lucier, chairman and CEO of Life Technologies Corp., on stem cells

"You want to have Track 1, 2, 3, 4 and 5 – if you only have Track 1 and Track 5, no one wants to give it a shot."

– William Hicks, partner with Mintz Levin, on the need to have multiple avenues to going public

"The hurdle rates for companies in development are being set higher than they have been in the past. Having said that, we love being in this industry."

– Anthony Marucci, president and CEO, Celldex Therapeutics Inc.